Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth.
Chandarlapaty S; Scaltriti M; Angelini P; Ye Q; Guzman M; Hudis CA; Norton L; Solit DB; Arribas J; Baselga J; Rosen N; Oncogene, 2010, vol. 29, issue 3, p 325, ISSN 14765594. ISBN 14765594.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef